Barbara Klencke Insider Profile

4 Followers
Barbara Klencke, CMO at Sierra Oncology, holds 0.00 shares in Sierra Oncology (Ticker: SRRA), holds ― shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 70.00K shares in TScan Therapeutics (Ticker: TCRX).
tipranks
Barbara Klencke

Barbara Klencke
Sierra Oncology (SRRA)
CMO

Ranked #35,726 out of 99,218 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+3.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$474K
73.14%
26.86%
0.00%
A breakdown of Barbara Klencke's holdings

Insider Roles

TScan Therapeutics
(TCRX)
Director
Xencor
(XNCR)
Director
eFFECTOR Therapeutics
(EFTR)
Director
Roles that Barbara Klencke holds in companies

Most Profitable Insider Trade

Stock:
Sierra Oncology
(SRRA)
Rating:Informative Buy
Date:Aug 18, 2020 - Aug 18, 2021
Return:+53.00%
The most profitable trade made by Barbara Klencke

Barbara Klencke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SRRA
Sierra Oncology
Jul 01, 2022
Uninformative Sell
825.00K
$0.00
eFFECTOR Therapeutics
Director
TScan Therapeutics
Sep 24, 2024
Director
Informative Buy
26.45K
$346.50K
Xencor
Jun 17, 2024
Director
Uninformative Buy
$127.26K
List of latest transactions for each holding click on a transaction to see Barbara Klencke's performance on stock

Barbara Klencke insider profile FAQ

What is the percentage of profitable transactions made by Barbara Klencke?
The percentage of profitable transactions made by Barbara Klencke is 40%.
    What is the average return per transaction made by Barbara Klencke?
    The average return per transaction made by Barbara Klencke is 3.80%.
      What stocks does Barbara Klencke hold?
      Barbara Klencke holds: SRRA, EFTR, TCRX, XNCR stocks.
        What was Barbara Klencke’s latest transaction?
        Barbara Klencke latest transaction was an Uninformative Sell of $825.00K.
          What was Barbara Klencke's most profitable transaction?
          Barbara Klencke’s most profitable transaction was an Informative Buy of SRRA stock on August 18, 2020. The return on the trade was 53.00%.
            What is Barbara Klencke's role in Sierra Oncology?
            Barbara Klencke's role in Sierra Oncology is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.